Carla Sancho-Mestre

Learn More
BACKGROUND The objective of the study is to estimate the frequency of multimorbidity in type 2 diabetes patients classified by health statuses in a European region and to determine the impact on pharmaceutical expenditure. METHODS Cross-sectional study of the inhabitants of a southeastern European region with a population of 5,150,054, using data(More)
Erratum Following the publication of this article [1] the authors would like to correct their ' Acknowledgments' section to read: " This work was supported by " Instituto de Salud Carlos III-Ministerio de Economía y Competitividad " and the European Union (FEDER funds) — FIS PI12/ 00037 ". The authors would like to thank members (Juan Bru and Inma Saurí) of(More)
BACKGROUND Pharmaceutical expenditure is undergoing very high growth, and accounts for 30% of overall healthcare expenditure in Spain. In this paper we present a prediction model for primary health care pharmaceutical expenditure based on Clinical Risk Groups (CRG), a system that classifies individuals into mutually exclusive categories and assigns each(More)
  • 1